[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. https://doi.org/10.3322/caac.21492
|
[2]
|
Walboomers, J.M., Jacobs, M.V., Manos, M.M., Bosch, F.X., Kummer, J.A., Shah, K.V., et al. (1999) Human Papillomavirus Is a Necessary Cause of Invasive Cervical Cancer Worldwide. The Journal of Pathology, 189, 12-19.
https://doi.org/10.1002/(SICI)1096-9896(199909)189:1%3C12::AID-PATH431%3E3.0.CO;2-F
|
[3]
|
Ho, G.Y., Burk, R.D., Klein, S., Kadish, A.S., Chang, C.J., Palan, P., et al. (1995) Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia. Journal of the National Cancer Institute, 87, 1365-1371. https://doi.org/10.1093/jnci/87.18.1365
|
[4]
|
Castle, P.E., Rodriguez, A.C., Burk, R.D., Herrero, R., Wacholder, S., Alfaro, M., et al. (2009) Short Term Persistence of Human Papillomavirus and Risk of Cervical Precancer and Cancer: Population Based Cohort Study. BMJ, 339, b2569. https://doi.org/10.1136/bmj.b2569
|
[5]
|
Kjaer, S.K., Frederiksen, K., Munk, C. and Iftner T. (2010) Long-Term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence. Journal of the National Cancer Institute, 102, 1478-1488. https://doi.org/10.1093/jnci/djq356
|
[6]
|
Roura, E., Castellsague, X., Pawlita, M., Travier, N., Waterboer, T., Margall, N., et al. (2014) Smoking as a Major Risk Factor for Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. International Journal of Cancer, 135, 453-466. https://doi.org/10.1002/ijc.28666
|
[7]
|
Eldridge, R.C., Pawlita, M., Wilson, L., Castle, P.E., Waterboer, T., Gravitt, P.E., et al. (2017) Smoking and Subsequent Human Papillomavirus Infection: A Mediation Analysis. Annals of Epidemiology, 27, 724-730.e1.
https://doi.org/10.1016/j.annepidem.2017.10.004
|
[8]
|
Moreno, V., Bosch, F.X., Munoz, N., Meijer, C.J., Shah, K.V., Walboomers, J.M., et al. (2002) Effect of Oral Contraceptives on Risk of Cervical Cancer in Women with Human Papillomavirus Infection: The IARC Multicentric Case-Control Study. Lancet, 359, 1085-1092. https://doi.org/10.1016/S0140-6736(02)08150-3
|
[9]
|
Munoz, N., Franceschi, S., Bosetti, C., Moreno, V., Herrero, R., Smith, J.S., et al. (2002) Role of Parity and Human Papillomavirus in Cervical Cancer: The IARC Multicentric Case-Control Study. Lancet, 359, 1093-1101.
https://doi.org/10.1016/S0140-6736(02)08151-5
|
[10]
|
Castle, P.E. and Giuliano, A.R. (2003) Chapter 4: Genital Tract Infections, Cervical Inflammation, and Antioxidant Nutrients—Assessing Their Roles as Human Papillomavirus Cofactors. Journal of the National Cancer Institute Monographs, 31, 29-34. https://doi.org/10.1093/oxfordjournals.jncimonographs.a003478
|
[11]
|
Curty, G., de Carvalho, P.S. and Soares, M.A. (2019) The Role of the Cervicovaginal Microbiome on the Genesis and as a Biomarker of Premalignant Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer. International journal of molecular sciences, 21, 222. https://doi.org/10.3390/ijms21010222
|
[12]
|
Witkin, S.S. and Linhares, I.M. (2017) Why Do Lactobacilli Dominate the Human Vaginal Microbiota? BJOG, 124, 606-611. https://doi.org/10.1111/1471-0528.14390
|
[13]
|
Mitra, A., Macintyre, D.A., Marchesi, J.R., Lee, Y.S., Bennett, P.R. and Kyrgiou M. (2016) The Vaginal Microbiota, Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia: What Do We Know and Where Are We Going Next? Microbiome, 4, Article No. 58. https://doi.org/10.1186/s40168-016-0203-0
|
[14]
|
Ravel, J., Gajer, P., Abdo, Z., Maria Schneider, G., Koenig, S.S.K., McCulle, S.L., et al. (2011) Vaginal Microbiome of Reproductive-Age Women. Proceedings of the National Academy of Sciences of the United States of America, 108, 4680-4687. https://doi.org/10.1073/pnas.1002611107
|
[15]
|
Agency for Healthcare Research and Quality (US) (2020) Cross-Sectional/Prevalence Study Quality.
http://www.ncbi.nlm.nih.gov/books/NBK35156/.
|
[16]
|
Lewis, J.R. and Sauro, J. (2006) When 100% Really Isn’t 100%: Improving the Accuracy of Small-Sample Estimates of Completion Rates. Journal of Usability Studies, 1, 136-150.
|
[17]
|
Gao, W., Weng, J., Gao, Y. and Chen, X. (2013) Comparison of the Vaginal Microbiota Diversity of Women with and without Human Papillomavirus Infection: A Cross-Sectional Study. BMC Infectious Diseases, 13, Article No. 271.
|
[18]
|
Shannon, B., Yi, T.J., Perusini, S., Gajer, P., Ma, B, Humphrys, M.S., et al. (2017) Association of HPV Infection and Clearance with Cervicovaginal Immunology and the Vaginal Microbiota. Mucosal Immunology, 10, 1310-1319.
|
[19]
|
Chen, Y., Qiu, X., Wang, W., Li, D., Wu, A., Hong, Z., et al. (2020) Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia Progression are Associated with Increased Vaginal Microbiome Diversity in a Chinese Cohort. BMC Infectious Diseases, 20, 629. https://doi.org/10.1186/s12879-020-05324-9
|
[20]
|
Brotman, R.M., Shardell, M.D., Gajer P., Gajer, P., Kathleen Tracy, J., Zenilman, J.M., et al. (2014) Interplay between the Temporal Dynamics of the Vaginal Microbiota and Human Papillomavirus Detection. The Journal of Infectious Diseases, 210, 1723-1733. https://doi.org/10.1093/infdis/jiu330
|
[21]
|
Borgdorff, H., Tsivtsivadze, E., Verhelst, R., Marzorati, M., Jurriaans, S., Ndayisaba, G.F., et al. (2014) Lactobacillus-Dominated Cervicovaginal Microbiota Associated with Reduced HIV/STI Prevalence and Genital HIV Viral Load in African Women. The ISME Journal, 8, 1781-1793.
|
[22]
|
Dareng, E.O., Ma, B., Famooto, A.O., Akarolo-Anthony, S.N., Offiong, R.A., Olaniyan, O., et al. (2016) Prevalent High-Risk HPV Infection and Vaginal Microbiota in Nigerian Women. Epidemiology & Infection, 144, 123-137.
https://doi.org/10.1017/S0950268815000965
|
[23]
|
Di Paola, M., Sani, C., Clemente, A.M., Iossa, A., Perissi, E., Castronovo, G., et al. (2017) Characterization of Cervico-Vaginal Microbiota in Women Developing Persistent High-Risk Human Papillomavirus Infection. Scientific Reports, 7, Article No. 10200. https://doi.org/10.1038/s41598-017-09842-6
|
[24]
|
Mitra, A., MacIntyre, D.A., Lee, Y.S., Smith, A., Marchesi, J.R., Lehne, B., et al. (2015) Cervical Intraepithelial Neoplasia Disease Progression is Associated with Increased Vaginal Microbiome Diversity. Scientific Reports, 5, Article ID: 16865. https://doi.org/10.1038/srep16865
|
[25]
|
Zhang, C., Liu, Y., Gao, W., Pan, Y., Gao, Y., Shen, J., et al. (2018) The Direct and Indirect Association of Cervical Microbiota with the Risk of Cervical Intraepithelial Neoplasia. Cancer Medicine, 7, 2172-2179.
https://doi.org/10.1002/cam4.1471
|
[26]
|
Audirac-Chalifour, A., Torres-Poveda, K., Bahena-Román, M., Téllez-Sosa, J., Martínez-Barnetche, J., Cortina-Ceballos, B., et al. (2016) Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study. PLoS ONE, 11, e0153274. https://doi.org/10.1371/journal.pone.0153274
|
[27]
|
Seo, S.S., Oh, H.Y., Lee, J.K., Kong, J.S., Lee, D.O. and Kim, M.K. (2016) Combined Effect of Diet and Cervical Microbiome on the Risk of Cervical Intraepithelial Neoplasia. Clinical Nutrition, 35, 1434-1441.
https://doi.org/10.1016/j.clnu.2016.03.019
|
[28]
|
Mitra, A., MacIntyre, D. A., Ntritsos, G., Smith, A., Tsilidis, K.K., Marchesi, J.R., Bennett, P.R., Moscicki, A.B. and Kyrgiou, M. (2020) The Vaginal Microbiota Associates with the Regression of Untreated Cervical Intraepithelial Neoplasia 2 Lesions. Nature Communications, 11, Article No. 1999. https://doi.org/10.1038/s41467-020-15856-y
|
[29]
|
Tu, Y.-K. (2016) Node-Splitting Generalized Linear Mixed Models for Evaluation of Inconsistency in Network Meta-Analysis. Value in Health the Journal of the International Society for Pharmacoeconomics & Outcomes Research, 19, 957-963. https://doi.org/10.1016/j.jval.2016.07.005
|
[30]
|
张天嵩, 董圣杰, 周支瑞. 高级meta分析方法: 基于stata实现[M]. 上海: 复旦大学出版, 2015.
|
[31]
|
Laniewski, P., Cui, H., Roe, D.J., Barnes, D., Goulder, A., Monk, B.J., et al. (2019) Features of the Cervicovaginal Microenvironment Drive Cancer Biomarker Signatures in Patients Across Cervical Carcinogenesis. Scientific Reports, 9, Article No. 7333. https://doi.org/10.1038/s41598-019-43849-5
|
[32]
|
Ilhan, Z.E., Laniewski, P., Thomas, N., Roe, D.J., Chase, D.M. and Herbst-Kralovetz, M.M. (2019) Deciphering the Complex Interplay between Microbiota, HPV, Inflammation and Cancer through Cervicovaginal Metabolic Profiling. EBioMedicine, 44, 675-690. https://doi.org/10.1016/j.ebiom.2019.04.028
|